Capital World Investors’s Integra LifeSciences IART Stock Holding History

Capital World Investors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,137,768	Closed	-$63.5M	–	546
2019 Q2	$63.5M	Buy	1,137,768 +775	+0.1%	+$39.9K	0.01%	328
2019 Q1	$63.4M	Hold	1,136,993	–	–	0.02%	327
2018 Q4	$51.3M	Sell	1,136,993 -22	-0%	-$1.21K	0.01%	339
2018 Q3	$74.9M	Buy	1,137,015 +926,015	+439%	+$57.5M	0.02%	341
2018 Q2	$13.6M	Buy	+211,000	New	+$13.1M	﹤0.01%	484

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors's IART Position: Q3 2019 in Review

Capital World Investors sold out of Integra LifeSciences (IART) in Q3 2019, closing a stake of 1,137,768 shares — an estimated $63.5M sold.

Capital World Investors first reported a position in IART in Q2 2018 and held it in 5 quarters. The position peaked at $74.9M in Q3 2018. 280 funds tracked by Wall St. Rank hold IART as of Q3 2019.

Capital World Investors reported no remaining Integra LifeSciences position as of Q3 2019 after selling out during the quarter.
Capital World Investors sold 1,137,768 Integra LifeSciences shares in Q3 2019, an estimated $63.5M.
Capital World Investors first reported a position in Integra LifeSciences in Q2 2018 and held it in 5 quarters.
Capital World Investors's Integra LifeSciences position peaked at $74.9M in Q3 2018.
280 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2019.

Based on Capital World Investors's 13F filing for Q3 2019, filed 14 Nov 2019.